Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults

Ear and Hearing

Volumn 27, Issue 5, 2006, Pages 466-479

  Dreisbach, Laura Elizabeth ^a   Long, Kelly Melissa ^b   Lees, Shannon Elizabeth ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b California Ear Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC REFLEX; ADULT; ARTICLE; AUDITORY RESPONSE; AUDITORY STIMULATION; AUDITORY THRESHOLD; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED OTOACOUSTIC EMISSION; FEMALE; HEARING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OTOACOUSTIC EMISSION;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PITCH PERCEPTION; REACTION TIME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33748522729     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aud.0000233892.37803.1a     Document Type: Article

References (60)

1. American Speech-Language-Hearing Association. (1989) Guidelines for screening for hearing impairment and middle ear disorders. ASHA;31, 71-77.
2. American Speech-Language-Hearing Association. (1994). Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA, 36(suppl.12), 11-19.
3. Arnold, D. J., Lonsbury-Martin, B. L., & Martin, G. K. (1999). High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions. Archives of Otolaryngology - Head and Neck Surgery, 125, 215-222.
4. Atherly, G. S. (1963). The reliability of repeated auditory threshold determination. British Journal of Industrial Medicine, 20, 231-235.
5. Beattie, R. C., & Bleech, J. (2000). Effects of sample size on the reliability of noise floor and DPOAE. British Journal of Audiology, 34, 305-309.
6. Beattie, R. C., Kenworthy, O. T., & Luna, C. A. (2003). Immediate and short-term reliability of distortion-product otoacoustic emissions. International Journal of Audiology, 42, 348-354.
7. Biro, K., Baki, M., Buki, B, Noszek, L., & Jokuti, L. (1997). Detection of early ototoxic effect in testicular-cancer patients treated with cisplatin by transiently evoked otoacoustic emission: a pilot study. Oncology, 54, 387-390.
8. Brown, A. M. (1987). Acoustic distortion from rodent ears: a comparison of responses from rats, guinea pigs, and gerbils. Hearing Research, 31, 25-38.
9. Brown, A. M., McDowell, B., & Forge, A. (1989). Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hearing Research, 42, 143-156.
10. Cacace, A. T., McClelland, W. A., Weiner, J., & McFarland, D. J. (1996). Individual differences and the reliability of 2F1-F2 distortion-product otoacoustic emissions: effects of time-of-day, stimulus variables, and gender. Journal of Speech and Hearing Research, 39 (6), 1138-1148.
11. Dobie, R. A. (1983). Time for action in hearing conservation. Otolaryngology and Head and Neck Surgery, 91, 347-349.
12. Dreisbach, L. E., & Siegel, J. H. (2001). Distortion-product otoacoustic emissions measured at high frequencies in humans. Journal of the Acoustical Society of America, 110, 2456-2469.
13. Dreisbach, L. E., & Siegel, J. H. (2005). Level dependence of distortion-product otoacoustic emissions measured at high frequencies in humans. Journal of the Acoustical Society of America, 117, 2980-2988.
14. Dunckley, K., & Dreisbach, L. E. (2004). Gender effects on high frequency distortion product otoacoustic emissions in humans. Ear & Hearing, 25, 554-564.
15. Eggermont, J. J., Brown, D. K., Ponton, C. W., & Kimberley, B. P. (1996). Comparison of distortion product otoacoustic emission (DPOAE) and auditory brain stem response (ABR) traveling wave delay measurements suggests frequency-specific synapse maturation. Ear & Hearing, 17, 386-394.
16. Engdahl, B., & Kemp, D. T. (1996). The effect of noise exposure on the details of distortion product otoacoustic emissions in humans. Journal of the Acoustical Society of America, 99, 1573-1587.
17. Fausti, S. A., Frey, R. H., Henry, J. A., Knutsen, J. L., & Olson, D. J. (1990). Reliability and validity of high-frequency (8-20 kHz) thresholds obtained on a computer-based audiometer as compared to a documented laboratory system. Journal of the American Academy of Audiology, 1, 162-170.
18. Fausti, S. A., Henry, J. A., Helt, W. J., Phillips, D. S., Frey, R. H., Noffsinger, P. D., Larson, V. D., & Fowler, C. G. (1999). An individualized, sensitive frequency range for early detection of ototoxicity. Ear & Hearing, 20, 497-505.
19. Fausti, S. A., Henry, J. A., Schaffer, H. I., Olson, D. J., Frey, R. H., & Bagby, G. C. (1993). High-frequency monitoring for early detection of cisplatin ototoxicity. Archives of Otolaryngology - Head & Neck Surgery, 119, 661-668.
20. Fausti, S. A., Henry, J. A., Schaffer, H. I., Olson, D. J., Frey, R. H., & McDonald, W. J. (1992). High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. The Journal of Infectious Diseases, 165, 1026-1032.
21. Fausti, S. A., Larson, V. D., Noffsinger, D., Wilson, R. H., Phillips, D. S., & Fowler, C. G. (1994). High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear & Hearing, 15, 232-239.
22. Frank, T. (1990). High-frequency hearing thresholds in young adults using a commercially available audiometer. Ear & Hearing, 11, 450-454.
23. Frank, T., & Dreisbach, L. E. (1991). Repeatability of high-frequency thresholds. Ear & Hearing, 12, 294-295.
24. Franklin, D. J., McCoy, M. J., Martin, G. K., & Lonsbury-Martin, B. L. (1992). Test/retest reliability of distortion-product and transiently evoked otoacoustic emissions. Ear & Hearing, 13, 417-429.
25. Gaskill, S. A., & Brown, A. M. (1990). The behavior of the acoustic distortion product, 2f1-f2, from the human ear and its relation to auditory sensitivity. Journal of the Acoustical Society of America, 88, 821-839.
26. Hall, A. J., & Lutman, M. E. (1999). Methods for early identification of noise-induced hearing loss. Audiology, 38, 277-280.
27. Harris, F. P., Lonsbury-Martin, B. L., Stagner, B. B., Coats, A. C., & Martin, G. K. (1989). Acoustic distortion products in humans: systematic changes in amplitudes as a function of f2/f1 ratio. Journal of the Acoustical Society of America, 85, 220-229.
28. Hauser, R., & Probst, R. (1991). The influence of systematic primary-tone level variation L2-L1 on the acoustic distortion product emission 2f1-f2 in normal human ears. Journal of the Acoustical Society of America, 89, 280-286.
29. Katbamna, B, Homnick, D. N., & Marks, J. H. (1999). Effects of chronic tobramycin treatment on distortion product otoacoustic emissions. Ear & Hearing, 20, 393-402.
30. Kemp, D. T. (1978). Stimulated acoustic emissions from within the human auditory system. Journal of the Acoustical Society of America, 64, 1386-1391.
31. Kimberley, B. P., Brown, D. K., & Eggermont, J. J. (1993). Measuring human cochlear traveling wave delay using distortion product emission phase responses. Journal of the Acoustical Society of America, 94, 1343-1350.
32. Kummer, P, Janssen, T., & Arnold, W. (1998). The level and growth behavior of the 2 f1-f2 distortion product otoacoustic emission and its relationship to auditory sensitivity in normal hearing and cochlear hearing loss. Journal of the Acoustical Society of America, 103, 3431-3444.
33. 2 primary tone level separation remains independent of test frequency in humans. Hearing Research, 146, 47-56.
34. Laukli, E., & Mair, I. W. S. (1985). High-frequency audiometry: normative studies and preliminary experiences. Scandinavian Audiology, 14, 151-158.
35. Liberman, M. C., & Dodds, L. W. (1984). Single-neuron labeling and chronic cochlear pathology, III: stereocilia damage and alterations of threshold tuning curves. Hearing Research, 16, 55-74.
36. Lonsbury-Martin, B. L., Martin, G. K., Probst, R., & Coats, A. C. (1987) Acoustic distortion products in rabbit ear canal, I: basic features and physiological vulnerability. Hearing Research 28:173-189.
37. Moulin, A., & Kemp, D. T. (1996). Multicomponent acoustic distortion product otoacoustic emission phase in humans, I: general characteristics. Journal of the Acoustical Society of America, 100, 1617-1639.
38. Mulheran, M., & Degg, C. (1997). Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects. British Journal of Audiology, 31, 5-9.
39. Namyslowski, G., Morawski, K, Trybalska, G., & Urbaniec, P. (2004). The latencies of the 2f1-f2 DPOAE measured using phase gradient method in young adults and in workers chronically exposed to noise. Otolaryngologia Polska, 58, 131-138.
40. Neely, S. T., & Liu, Z. (1993). EMAV: otoacoustic emission averager. Tech Memo No. 17 (Boys Town National Research Hospital, Omaha).
41. O'Mahoney, C. F, & Kemp, D. T. (1995). Distortion product otoacoustic emission delay measurement in human ears. Journal of the Acoustical Society of America, 97, 3721-3735.
42. Rasmussen, A. N., Popelka, G. R., Osterhammel, P. A, & Nielsen, L. H. (1993). Clinical significance of relative probe-tone levels on distortion product otoacoustic emissions. Scandinavian Audiology, 22, 223-229.
43. Ress, B. D., Sridhar, K. S., Balkany, T. J., Waxman, G. M., Stagner, B. B., & Lonsbury-Martin, B. L. (1999). Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol: third place - Resident Clinical Science Award 1998. Otolaryngology and Head and Neck Surgery, 121, 693-701.
44. Roede, J., Harris, F. P., Probst, R., & Xu, L. (1993). Repeatability of distortion product otoacoustic emissions in normally hearing humans. Audiology, 32, 273-281.
45. Ruggero, M. A., & Rich, N. C. (1991). Application of a commercially-manufactured Doppler-shift laser velocimeter to the measurement of basilar-membrane vibration. Hearing Research, 51, 215-230.
46. Shehata-Dieler, W. E., Dieler, R, Teichert, K., & Moser, L. M. (1999). Intra- and intersubject variability of acoustically evoked otoacoustic emissions, II: distortion product otoacoustic emissions. Laryngorhinootologie, 78, 345-350.
47. Shera, C. A., Talmadge, C. L., & Tubis, J. (2000). Interrelations among distortion-product phase-gradient delays: their connection to scaling symmetry and its breaking. Journal of the Acoustical Society of America, 108, 2933-2948.
48. Siegel, J. H. (1994). Ear-canal standing waves and high-frequency sound calibration using otoacoustic emission probes. Journal of the Acoustical Society of America, 95, 2589-2597.
49. Siegel, J. H. (2002). Calibrating otoacoustic emission probes. In: R. Glattke (Ed.). Otoacoustic Emissions: Clinical Applications. Thieme.
50. Stavroulaki, P., Nikolopoulos, T. P., Psarommatis, I., & Apostolopoulos, N. (2001). Hearing evaluation with distortion-product otoacoustic emissions in young patients undergoing haemodialysis. Clinical Otolaryngology, 26, 235-242.
51. Stavroulaki, P., Vossinakis, I. C., Dinopoulou, D., Doudounakis, S, Adamopoulos, G., & Apostolopoulos, N. (2002). Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis. Archives of Otolaryngology - Head & Neck Surgery, 128, 150-155.
52. Stover, L. J., Gorga, M. P., Neely, S. T., & Montoya, D. (1996). Toward optimizing the clinical utility of distortion product otoacoustic emission measurements. Journal of the Acoustical Society of America, 100, 956-967.
53. Stover, L. J., Neely, S. T., & Gorga, M. P. (1996). Latency and multiple sources of distortion product otoacoustic emissions. Journal of the Acoustical Society of America, 99, 1016-1024.
54. Telischi, F. F., Stagner, B. B., Widick, M. P., Balkany, T. J., & Lonsbury-Martin, B. L. (1998). Distortion-product otoacoustic emission monitoring of cochlear blood flow. The Laryngoscope, 108, 837-842.
55. Whitehead, M. L., Lonsbury-Martin, B. L., & Martin, G. K.. (1990). Actively and passively generated acoustic distortion at 2f1-f2 in rabbits. In P. Dallos, C. D. Geisler, J. W. Matthews, M. A. Ruggero & C. R. Steele (Eds.). Mechanics and Biophysics of Hearing. (pp. 243-250). New York: Springer-Verlag.
56. Whitehead, M. L., Stagner, B. B., Lonsbury-Martin, B. L., & Martin, G. K. (1994). Comparison of the onset latency and group latency of distortion-product otoacoustic emissions in human ears. Association for Research in Otolaryngology Abstract, 17, 46.
57. Whitehead, M. L., Stagner, B. B., Martin, G. K., & Lonsbury-Martin, B. L. (1996). Visualization of the onset of distortion-product otoacoustic emissions, and measurement of their latency. Journal of the Acoustical Society of America, 100, 1663-1679.
58. Whitehead, M. L., Stagner, B. B., McCoy, M. J., Lonsbury-Martin, B. L., & Martin, G. K. (1995). Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears, II: asymmetry in L1,L2 space. Journal of the Acoustical Society of America, 97, 2359-2377.
59. Wiederhold, M. L., Mahoney, J. W., & Kellogg, D. L. (1986). Acoustic overstimulation reduces 2f1-f2 cochlear emissions at all levels in the cat. In J. B. Allen, J. L. Hall, A. Hubbard, S. T. Neely & A. Tubis (Eds.). Peripheral Auditory Mechanisms. (pp. 322-329). New York: Springer.
60. Zhao, F., & Stephens, D. (1999). Test-retest variability of distortion-product otoacoustic emissions in human ears with normal hearing. Scandinavian Audiology, 28, 171-178.